Eligibility of C-BIOPRED severe asthma cohort for type-2 biologic therapies

二维码有效期 120s

作者 Deng Zhenan ^[1] Jin Meiling ^[2] Ou Changxing ^[3] Jiang Wei ^[4] Zhao Jianping ^[5] Liu Xiaoxia ^[6] Sun Shenghua ^[7] Tang Huaping ^[8] He Bei ^[9] Cai Shaoxi ^[10] Chen Ping ^[29] Wu Penghui ^[1] Liu Yujing ^[4] Kang Jian ^[12] Zhang Yunhui ^[13] Huang Mao ^[14] Xu Jinfu ^[15] Huang Kewu ^[16] Li Qiang ^[17] Zhang Xiangyan ^[18] Fu Xiuhua ^[19] Wang Changzheng ^[20] Shen Huahao ^[21] Zhu Lei ^[2] Shi Guochao ^[22] Qiu Zhongmin ^[23] Wen Zhongguang ^[24] Wei Xiaoyang ^[25] Gu Wei ^[26] Wei Chunhua ^[27] Wang Guangfa ^[28] Xie Lixin ^[30] Lin Jiangtao ^[31] Tang Yuling ^[32] Han Zhihai ^[33] Chung Kian Fan ^[34] Zhang Qingling ^[1] Zhong Nanshan ^[1] 学术成果认领

作者单位 Pulmonary and Critical Care Medicine, Guangzhou Institute of Respiratory Health, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, State Key Laboratory of Respiratory Diseases, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510120, China ^[1] Department of Respiratory Medicine, Zhongshan Hospital, Shanghai 200433, China ^[2] Guangzhou Medical University, Guangzhou, Guangdong 510180, China ^[3] AstraZeneca, Shanghai 200085, China ^[4] Department of Respiratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China ^[5] Department of Respiratory Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China ^[6] Department of Respiratory Medicine, The Third Xiangya Hospital of Central South University, Changsha, Hunan 410013, China ^[7] Department of Respiratory Medicine, Qingdao Municipal Hospital, Qingdao, Shandong 266001, China ^[8] Department of Respiratory Medicine, Peking University Third Hospital, Beijing 100191, China ^[9] Department of Respiratory Medicine, Nanfang Hospital of Southern Medical University, Guangzhou, Guangdong 510515, China ^[10] Department of Respiratory Medicine, General Hospital of Northern Theater Command, Shenyang, Liaoning 110016, China ^[11] Department of Respiratory Medicine, The First Hospital of China Medical University, Shenyang, Liaoning 110001, China ^[12] Department of Respiratory Medicine, The First people’s Hospital of Yunnan Province, Kunming, Yunnan 363880, China ^[13] Department of Respiratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China ^[14] Department of Respiratory Medicine, Shanghai Pulmonary Hospital, Shanghai 200433, China ^[15] Department of Respiratory Medicine, Beijing Chao-Yang Hospital, Beijing 100020, China ^[16] Department of Respiratory Medicine, Shanghai General Hospital, Shanghai 200080, China ^[17] Department of Respiratory Medicine, Guizhou Province People’s Hospital, Guiyang, Guizhou 550002, China ^[18] Department of Respiratory Medicine, The Affiliated Hospital of Inner Mongolia Medical University, Huhhot, Inner Mongolia 010050, China ^[19] Department of Respiratory Medicine, The Third Affiliated Hospital of Chongqing Medical University, Chongqing 401120, China ^[20] Department of Respiratory Medicine, The Second Affiliated hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310003, China ^[21] Department of Respiratory Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China ^[22] Department of Pulmonary and Critical Care Medicine, Tongji Hospital, School of Medicine, Tongji University, Shanghai 200065, China ^[23] Department of Respiratory Medicine, The First Affiliated Hospital of PLA General Hospital, Beijing 100048, China ^[24] Department of Respiratory and Critical Care Medicine, The Eighth Medical Center of PLA General Hospital, Beijing 100048, China ^[25] Department of Respiratory, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu 210029, China ^[26] Department of Respiratory Medicine, Weifang Weien Hospital, Weifang, Shandong 261045, China ^[27] Department of Respiratory Medicine, Peking University First Hospital, Beijing 100034, China ^[28] Department of Respiratory Medicine, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China ^[29] College of Pulmonary and Critical Care Medicine, Chinese PLA General Hospital, Beijing 100853, China ^[30] Department of Respiratory Medicine, China-Japan Friendship Hospital, Beijing 100029, China ^[31] Department of Respiratory Medicine, The First Hospital of Changsha, Changsha, Hunan 410005, China ^[32] Deparment of Pulmonary and Critical Care Medicine, The Sixth Medical Center of PLA General Hospital, Beijing 100048, China ^[33] National Heart and Lung Institute, Imperial College London, London SW3, UK ^[34]

栏目名称 Correspondence

DOI 10.1097/CM9.0000000000002556

发布时间 2025-03-04

基金项目

AstraZeneca, China, and the National Natural Science Foundation of China